InvestorsHub Logo
Followers 3156
Posts 961111
Boards Moderated 205
Alias Born 09/04/2000

Re: Johnny_C post# 1079

Tuesday, 03/17/2020 3:45:56 PM

Tuesday, March 17, 2020 3:45:56 PM

Post# of 6079
BioNTech Soars on Coronavirus Tie-Up With Pfizer -- Market Talk
11:07 am ET March 17, 2020 (Dow Jones) Print
1506 GMT - Shares in BioNTech rise 60% after the company and drug giant Pfizer agreed to co-develop and distribute a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infections. The companies said the agreement would enable them to immediately start working together to speed up BioNTech's development of its potential first-in-class Covid-19 mRNA vaccine program, BNT162, which is expected to enter clinical testing by the end of April. The pair said the move would build on an existing partnership launched in 2018 to develop mRNA-based influenza vaccines. "BioNTech appears best positioned in the COVID-19 race owing to its diversified mRNA platform, delivery formulation and manufacturing capacity," Berenberg says. (philip.waller@wsj.com)

(END) Dow Jones Newswires

March 17, 2020 11:07 ET (15:07 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

https://investorshub.advfn.com/BioNTech-SE-ADR-BNTX-37289/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News